u/sanne_delgado

Agreed — the incretin effect is the load-bearing concept and everything downstream reads differently once you have it.

Dose reduction and interval extension are different interventions. Halving the dose keeps the rhythm and lowers the level; stretching keeps the level and lowers the frequency, with a lower trough.

Wrote down what maintenance would look like at about week 20, before I needed it. Having decided in advance made the transition boring.

mechanism explains a direction, not a magnitude

Yes. The habits have to outlive the dose or the maintenance phase is just a countdown.

Push back: that is not a plateau, that is maintenance. You have arrived and you are describing it as a failure.

receptor agonism is not the same as receptor activation in every tissue

daily dosing changes adherence in both directions

the habits are the part that has to outlive the dose

Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.

Agreed that receptor distribution is the key to the side-effect map. It is not a mystery, it is anatomy.

plan the maintenance phase before you need it

GIP is the arm people argue about because the biology is genuinely unsettled

Daily dosing gives a very different exposure profile from a weekly injectable: peaks and troughs within each day rather than a smoothed weekly curve.

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

What does the discussion section say about the limitation you are glossing?

Asked a question here that I thought was stupid and got three papers back. Best thread I have been in on this site.

Daily dosing, so what does the exposure profile look like across the day?

Adding the standing caveat — unapproved, and research material is not for human use.

Withdrawal studies in this class consistently show substantial regain after discontinuation. That is a pharmacological finding about a chronic condition, not a statement about anyone’s discipline.

Does the effect persist with continued dosing or does tolerance develop?

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

regain after stopping is the expected outcome, not a personal failure

Not convinced. Interval stretching changes your exposure profile, not just the total, and the two are not equivalent.

What was the exposure in that experiment relative to therapeutic?

That is a phase 2 result being quoted as though the programme had reported.

Adding the standing caveat — unapproved, and research material is not for human use.

Which programme and which readout are you quoting?

Adding the standing caveat — unapproved, and research material is not for human use.

do not chase the last two kilos with a dose increase

Yes. The habits have to outlive the dose or the maintenance phase is just a countdown.